Benzinga | Aug 18, 2020 06:23AM EDT

HC Wainwright & Co. Maintains Buy on Microbot Medical, Raises Price Target to $20

HC Wainwright & Co. maintains Microbot Medical (NASDAQ:MBOT) with a Buy and raises the price target from $19 to $20.